Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Ludwig Laugwitz

Showing results (1-10 of 417) with videos related to

Pageof 42
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 11, 2022
[Functional cardiovascular symptoms]Peter Henningsen, Karl-Ludwig Laugwitz
Pharmacology & Therapeutics|March 25, 2014
Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testingDaniel Sinnecker, Karl-Ludwig Laugwitz, Alessandra Moretti
Circulation Research|August 30, 2014
Extending human induced pluripotent stem cell technology to infectious diseases: new model for viral myocarditisDaniel Sinnecker, Karl-Ludwig Laugwitz, Alessandra Moretti
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2020
Left Ventricular Pressure Volume Loop Measurements Using Conductance Catheters to Assess Myocardial Function in MiceTilman Ziegler, Karl-Ludwig Laugwitz, Christian Kupatt
European Heart Journal|April 16, 2013
Negating the dominant-negative allele: a new treatment paradigm for arrhythmias explored in human induced pluripotent stem cell-derived cardiomyocytesDaniel Sinnecker, Alessandra Moretti, Karl-Ludwig Laugwitz
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 11, 2016
Comprehensive endovascular treatment of multiple arterial emboli involving LIMA graft, distal aorta and upper and lower extremities in a patient with subacute cerebral hemorrhageNicolas Langwieser, Karl-Ludwig Laugwitz, Tareq Ibrahim
Developmental Cell|December 15, 2010
MicroRNAs in a cardiac loop: progenitor or myocyte?Sylvia M Evans, Alessandra Moretti, Karl-Ludwig Laugwitz
Science (New York, N.Y.)|October 9, 2004
Development. ES cells to the rescueKenneth R Chien, Alessandra Moretti, Karl-Ludwig Laugwitz
Pediatric Cardiology|May 6, 2009
Multipotent progenitor cells in regenerative cardiovascular medicineJason T Lam, Alessandra Moretti, Karl-Ludwig Laugwitz
Circulation Research|April 10, 2013
Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia researchDaniel Sinnecker, Alexander Goedel, Karl-Ludwig Laugwitz, et al.
Pageof 42

Showing results (1-10 of 417) with videos related to

Sort By:
Pageof 42
Deutsche Medizinische Wochenschrift (1946)|May 11, 2022
[Functional cardiovascular symptoms]Peter Henningsen, Karl-Ludwig Laugwitz
Pharmacology & Therapeutics|March 25, 2014
Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testingDaniel Sinnecker, Karl-Ludwig Laugwitz, Alessandra Moretti
Circulation Research|August 30, 2014
Extending human induced pluripotent stem cell technology to infectious diseases: new model for viral myocarditisDaniel Sinnecker, Karl-Ludwig Laugwitz, Alessandra Moretti
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2020
Left Ventricular Pressure Volume Loop Measurements Using Conductance Catheters to Assess Myocardial Function in MiceTilman Ziegler, Karl-Ludwig Laugwitz, Christian Kupatt
European Heart Journal|April 16, 2013
Negating the dominant-negative allele: a new treatment paradigm for arrhythmias explored in human induced pluripotent stem cell-derived cardiomyocytesDaniel Sinnecker, Alessandra Moretti, Karl-Ludwig Laugwitz
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 11, 2016
Comprehensive endovascular treatment of multiple arterial emboli involving LIMA graft, distal aorta and upper and lower extremities in a patient with subacute cerebral hemorrhageNicolas Langwieser, Karl-Ludwig Laugwitz, Tareq Ibrahim
Developmental Cell|December 15, 2010
MicroRNAs in a cardiac loop: progenitor or myocyte?Sylvia M Evans, Alessandra Moretti, Karl-Ludwig Laugwitz
Science (New York, N.Y.)|October 9, 2004
Development. ES cells to the rescueKenneth R Chien, Alessandra Moretti, Karl-Ludwig Laugwitz
Pediatric Cardiology|May 6, 2009
Multipotent progenitor cells in regenerative cardiovascular medicineJason T Lam, Alessandra Moretti, Karl-Ludwig Laugwitz
Circulation Research|April 10, 2013
Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia researchDaniel Sinnecker, Alexander Goedel, Karl-Ludwig Laugwitz, et al.
Pageof 42